| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 3,410 | $90 | $300K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 770 | $130 | $98.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 690 | $60 | $41.8K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 430 | $70 | $30.7K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 90 | $280 | $25.1K |
| 99495 | The provider manages the care of a patient during the transition to home care after discharge from a healthcare facility. The patient’s care requires at least moderate medical decision making,… | 100 | $160 | $15.7K |
| G0444 | Annual depression screening, 5 to 15 minutes | 760 | $20 | $13.7K |
| G0008 | Administration of influenza virus vaccine | 430 | $30 | $12.9K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 320 | $40 | $11.1K |
| 87400 | The lab analyst performs the technical lab test to detect antigens of influenza A or B using an immunoassay technique, such as EIA. This analysis will distinguish if a patient has influenza A or B. | 610 | $10 | $8.6K |